Regenerative Biologics



 

Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows a user to regulate and select a desired cell type through a patented collection window and integrated ultra-filtration system.

Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.

Technologies developed by Celling Biosciences collect, process and deliver autologous cells to the patient at the point of care. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process.

The ART PLUS Family of products is the only integrated ultra-filtration system on the market that allows for the processing of bone marrow, peripheral blood and growth factors at the point of care.

 

RxBIO is dedicated to the advancement of autologous cell therapy movement. RxBIO will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.

Technologies developed by RxBIO collect, process and deliver autologous cells. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process.


PLATELET RICH PLASMA (PRP)


ART PRP™

ART PRP™

The ART PRP™ concentration system processes autologous whole blood effectively and efficiently at the point of care. The system recovers the greatest percentage of platelets and growth factors by allowing selection of the platelet concentrate from user defined portions of a centrifuged stack of fluid.

  • Thumb wheel technology for efficient stack layer extraction
  • Adjustable flow valve diverts fluid without additional sterile breaks
  • Variable processing volume supports a variety of applications
  • This system is a miniaturized laboratory in a single-use sterile device.
  • The back reservoir chamber may be used to store the plasma without breaking sterility.

Learn More


ART PRP PLUS™ (1)

ART PRP PLUS™

The ART PRP PLUS™ system has an integrated filter system for the ultrafiltration of proteins from platelet poor plasma (PPP) to create a fluid rich in growth factors.

  • Integrated nano-pore fiber system
  • Closed system technology limits sterile breaks
  • Thumb wheel technology allows precise recovery of targeted cell layer in the collection zone
  • During this process, water and salt ions are pushed out while the beneficial proteins are retained and concentrated.
  • The PPP can be passed multiple times from syringe to syringe through the filter until the desired volume is obtained.
  • This ultra-filtration enriches the concentration of most proteins like VEGF, PDGF, TGF-Beta, FGF, Alpha-2 Macroglobulin (A2M), Interleukin-1 receptor antagonist protein (IRAP) and Fibrinogen.
Learn More

BONE MARROW CONCENTRATE (BMC)


ART BMC™ (1)

ART BMC™

The ART BMC™ concentration system recovers a high percentage of nucleated, progenitor and other cells by allowing selection of the cell concentrate from user-defined portions of the centrifuged stack. This miniaturized laboratory is designed as a single use sterile device that delivers a safe handling of cells.

  • Functionally closed system limits sterile breaks
  • Processes up to 60cc of aspirate
  • Thumb wheel allows precise selection of fluid stack
  • The ART BMC systems processes autologous bone marrow concentrate effectively and efficiently at point-of-care
  • The back reservoir chamber may be used to store the plasma without breaking sterility

Learn More

ART BMC PLUS™ (1)

ART BMC PLUS™

The ART BMC PLUS™ features an integrated filter system for the ultrafiltration of proteins from bone derived from bone marrow.

  • Efficient concentration yields of ultra low hematocrit
  • Concentration of molecules including: fibrinogen, alpha-2-maro globulin and cytokines
  • Consistently high yields of mononuclear cells
  • The ART BMC Plus has an integrated filter system for the concentration of proteins from Platelet Poor Plasma (PPP) to create a fluid rich in growth factors
  • During this process, water and salt ions are pushed out while the beneficial proteins are retained and concentrated
  • The PPP can be passed multiple times from syringe to syringe through the filter until the desired volume is obtained
  • This ultra-filtration enriches the concentration of most proteins like VEGF, PDGF, TGF-Beta, FGF, Alpha-2 Macroglobulin (A2M), Interleukin-1 receptor antagonist protein (IRAP) and Fibrinogen
Learn More

Have Questions?



To learn more please email us at [email protected] or call (905) 780-3200.